241 related articles for article (PubMed ID: 18988696)
1. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.
Lu H; Kaplan BL; Ngaotepprutaram T; Kaminski NE
J Leukoc Biol; 2009 Feb; 85(2):322-9. PubMed ID: 18988696
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells.
Ngaotepprutaram T; Kaplan BL; Crawford RB; Kaminski NE
J Neuroimmune Pharmacol; 2012 Dec; 7(4):969-80. PubMed ID: 22851303
[TBL] [Abstract][Full Text] [Related]
3. Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.
Ngaotepprutaram T; Kaplan BL; Kaminski NE
Toxicol Appl Pharmacol; 2013 Nov; 273(1):209-18. PubMed ID: 23999542
[TBL] [Abstract][Full Text] [Related]
4. Regulation of mouse inducible costimulator (ICOS) expression by Fyn-NFATc2 and ERK signaling in T cells.
Tan AH; Wong SC; Lam KP
J Biol Chem; 2006 Sep; 281(39):28666-78. PubMed ID: 16880206
[TBL] [Abstract][Full Text] [Related]
5. T helper cell-specific regulation of inducible costimulator expression via distinct mechanisms mediated by T-bet and GATA-3.
Tan AH; Goh SY; Wong SC; Lam KP
J Biol Chem; 2008 Jan; 283(1):128-136. PubMed ID: 17986443
[TBL] [Abstract][Full Text] [Related]
6. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
[TBL] [Abstract][Full Text] [Related]
7. Repressor of GATA-3 can negatively regulate the expression of T cell cytokines through modulation on inducible costimulator.
Zang YS; Fang Z; Liu YA; Li B; Xiu QY
Chin Med J (Engl); 2012 Jun; 125(12):2188-94. PubMed ID: 22884151
[TBL] [Abstract][Full Text] [Related]
8. Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events.
Karmaus PW; Chen W; Kaplan BL; Kaminski NE
J Neuroimmune Pharmacol; 2012 Dec; 7(4):843-55. PubMed ID: 21789506
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of inducible costimulator-ligand splice variants: lymphoid regulation of mouse GL50-B and human GL50 molecules.
Ling V; Wu PW; Miyashiro JS; Marusic S; Finnerty HF; Collins M
J Immunol; 2001 Jun; 166(12):7300-8. PubMed ID: 11390480
[TBL] [Abstract][Full Text] [Related]
10. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).
Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R
J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664
[TBL] [Abstract][Full Text] [Related]
11. Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function.
Schatz AR; Koh WS; Kaminski NE
Immunopharmacology; 1993; 26(2):129-37. PubMed ID: 8282537
[TBL] [Abstract][Full Text] [Related]
12. Effects of double blockade of CD28 and inducible-costimulator signaling on anti-glomerular basement membrane glomerulonephritis.
Okano K; Nitta K; Ogawa S; Horita S; Habiro K; Nihei H; Abe R
J Lab Clin Med; 2004 Oct; 144(4):183-92. PubMed ID: 15514586
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family.
Tezuka K; Tsuji T; Hirano D; Tamatani T; Sakamaki K; Kobayashi Y; Kamada M
Biochem Biophys Res Commun; 2000 Sep; 276(1):335-45. PubMed ID: 11006126
[TBL] [Abstract][Full Text] [Related]
14. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1.
Taylor A; Akdis M; Joss A; Akkoç T; Wenig R; Colonna M; Daigle I; Flory E; Blaser K; Akdis CA
J Allergy Clin Immunol; 2007 Jul; 120(1):76-83. PubMed ID: 17531298
[TBL] [Abstract][Full Text] [Related]
15. Critical role of inducible costimulator signaling in the development of arteriosclerosis.
Kosuge H; Suzuki J; Haraguchi G; Koga N; Maejima Y; Inobe M; Isobe M; Uede T
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2660-5. PubMed ID: 16990558
[TBL] [Abstract][Full Text] [Related]
16. AILIM/ICOS: its expression and functional analysis with monoclonal antibodies.
Sakamoto S; Tezuka K; Tsuji T; Hori N; Tamatani T
Hybrid Hybridomics; 2001; 20(5-6):293-303. PubMed ID: 11839247
[TBL] [Abstract][Full Text] [Related]
17. AP-1 is involved in ICOS gene expression downstream of TCR/CD28 and cytokine receptor signaling.
Watanabe M; Nakajima S; Ohnuki K; Ogawa S; Yamashita M; Nakayama T; Murakami Y; Tanabe K; Abe R
Eur J Immunol; 2012 Jul; 42(7):1850-62. PubMed ID: 22585681
[TBL] [Abstract][Full Text] [Related]
18. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.
Tanaka C; Fujimoto M; Hamaguchi Y; Sato S; Takehara K; Hasegawa M
Arthritis Rheum; 2010 Jun; 62(6):1723-32. PubMed ID: 20191584
[TBL] [Abstract][Full Text] [Related]
19. ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses.
Gonzalo JA; Tian J; Delaney T; Corcoran J; Rottman JB; Lora J; Al-garawi A; Kroczek R; Gutierrez-Ramos JC; Coyle AJ
Nat Immunol; 2001 Jul; 2(7):597-604. PubMed ID: 11429543
[TBL] [Abstract][Full Text] [Related]
20. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.
Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA
Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
